Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Go back to Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing| Fabien Corp (NASDAQ: FBIO) | Delayed: 2.69 -0.03 (1.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.72 | 52 Week High | $4.66 | |||
| Open | $2.69 | 52 Week Low | $2.01 | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $0.00 | |||
| Volume | 29,777 | |||||
